{
    "title": "BREAST CANCER AND DIAGNOSTIC METHODS: UNDERSTANDING THE ROLE OF BRCA1 AND BRCA2.",
    "doc_id": "39724887",
    "writer": "Borges J",
    "year": "2024",
    "summary": "Breast cancer is a disease that has a 1 in 8 lifetime risk for women, making it an international burden. Although breast cancer mostly affects women, men have a lifetime risk of around 1 in 1000. The majority of breast cancer instances co â€¦",
    "abstract": "Breast cancer is a disease that has a 1 in 8 lifetime risk for women, making it an international burden. Although breast cancer mostly affects women, men have a lifetime risk of around 1 in 1000. The majority of breast cancer instances continue linked to breast cancers that have acquired somatic mutations during a person's lifespan. The mutations that are in the situation do not cluster in families and are not inherited. The particular genetic variables involved in hereditary breast cancer will define a cancer risk due to genetics. Despite fact, Cadherin-1(CDH1), Phosphatase and TENsin (PTEN), Partner and Localizer of BRCA2 (PALB2), serine/threonine kinase 11 (STK11), Checkpoint kinase 2 (CHEK2), and tumor protein 53 (TP53) genes have mutations, a BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) genes, documented to inherit significantly increase a chance of developing BRCA. Recognizing the functional importance of genetic mutations has created avenues to prevent breast cancer and is revealing promising therapeutic approaches.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/39724887/",
    "clean_text": "breast cancer and diagnostic methods understanding the role of brca and brca breast cancer is a disease that has a in lifetime risk for women making it an international burden although breast cancer mostly affects women men have a lifetime risk of around in the majority of breast cancer instances co breast cancer is a disease that has a in lifetime risk for women making it an international burden although breast cancer mostly affects women men have a lifetime risk of around in the majority of breast cancer instances continue linked to breast cancers that have acquired somatic mutations during a person s lifespan the mutations that are in the situation do not cluster in families and are not inherited the particular genetic variables involved in hereditary breast cancer will define a cancer risk due to genetics despite fact cadherin cdh phosphatase and tensin pten partner and localizer of brca palb serine threonine kinase stk checkpoint kinase chek and tumor protein tp genes have mutations a breast cancer gene brca and breast cancer gene brca genes documented to inherit significantly increase a chance of developing brca recognizing the functional importance of genetic mutations has created avenues to prevent breast cancer and is revealing promising therapeutic approaches"
}